Last Close
47.24 $
Jul 6, 26
Market Cap
2.7 B $
Q1 2026 (TTM)
52-Week Range
%+50.2
%36.5
0.21
0.21
%-17.1
-%23.5
1M
+5.6%
3M
-6.5%
6M
-4.4%
YTD
-4.9%
1Y
+47.7%
3Y
+59.4%
Returns are computed from split-adjusted closes; dividends are not included.
Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.
SUPN last closed at 47.24 $ (Jul 6, 26). Price data is refreshed after every trading day.
Supernus Pharmaceuticals Inc (SUPN) has a market capitalization of approximately 2.7 B $ as of the latest reported period.
Key peers of Supernus Pharmaceuticals Inc include Laboratorios Farmaceuticos ROVI, Bausch Health Companies Inc, EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, Haleon PLC. A detailed metric comparison is available on the Peers tab.
Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.